nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Methylprednisolone—multiple sclerosis	0.0708	0.174	CrCtD
Fludrocortisone—Betamethasone—multiple sclerosis	0.0696	0.172	CrCtD
Fludrocortisone—Dexamethasone—multiple sclerosis	0.0696	0.172	CrCtD
Fludrocortisone—Triamcinolone—multiple sclerosis	0.068	0.168	CrCtD
Fludrocortisone—Prednisone—multiple sclerosis	0.0646	0.159	CrCtD
Fludrocortisone—Prednisolone—multiple sclerosis	0.063	0.155	CrCtD
Fludrocortisone—NR3C2—Betamethasone—multiple sclerosis	0.0509	0.217	CbGbCtD
Fludrocortisone—NR3C2—Prednisolone—multiple sclerosis	0.0502	0.214	CbGbCtD
Fludrocortisone—NR3C2—Dexamethasone—multiple sclerosis	0.0296	0.126	CbGbCtD
Fludrocortisone—NR3C1—Methylprednisolone—multiple sclerosis	0.0258	0.11	CbGbCtD
Fludrocortisone—NR3C1—Triamcinolone—multiple sclerosis	0.0196	0.0833	CbGbCtD
Fludrocortisone—NR3C1—Betamethasone—multiple sclerosis	0.0168	0.0715	CbGbCtD
Fludrocortisone—NR3C1—Prednisolone—multiple sclerosis	0.0166	0.0705	CbGbCtD
Fludrocortisone—NR3C1—Prednisone—multiple sclerosis	0.0156	0.0666	CbGbCtD
Fludrocortisone—NR3C1—Dexamethasone—multiple sclerosis	0.00976	0.0416	CbGbCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.0037	0.0137	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00361	0.0134	CrCrCtD
Fludrocortisone—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.00329	0.0122	CrCrCtD
Fludrocortisone—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00318	0.0118	CrCrCtD
Fludrocortisone—Flurandrenolide—Betamethasone—multiple sclerosis	0.00313	0.0116	CrCrCtD
Fludrocortisone—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00313	0.0116	CrCrCtD
Fludrocortisone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00297	0.011	CrCrCtD
Fludrocortisone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00288	0.0107	CrCrCtD
Fludrocortisone—Flurandrenolide—Prednisolone—multiple sclerosis	0.00283	0.0105	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—multiple sclerosis	0.00271	0.0101	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisolone—multiple sclerosis	0.00265	0.00982	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00264	0.00979	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—multiple sclerosis	0.00263	0.00975	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.0026	0.00964	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.0026	0.00964	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00257	0.00952	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00254	0.00942	CrCrCtD
Fludrocortisone—Amcinonide—Dexamethasone—multiple sclerosis	0.00253	0.00938	CrCrCtD
Fludrocortisone—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00253	0.00938	CrCrCtD
Fludrocortisone—Amcinonide—Betamethasone—multiple sclerosis	0.00253	0.00938	CrCrCtD
Fludrocortisone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00253	0.00938	CrCrCtD
Fludrocortisone—Diflorasone—Methylprednisolone—multiple sclerosis	0.0025	0.00928	CrCrCtD
Fludrocortisone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.0025	0.00928	CrCrCtD
Fludrocortisone—Desonide—Methylprednisolone—multiple sclerosis	0.0025	0.00928	CrCrCtD
Fludrocortisone—Prednisone—Methylprednisolone—multiple sclerosis	0.0025	0.00928	CrCrCtD
Fludrocortisone—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00247	0.00917	CrCrCtD
Fludrocortisone—Amcinonide—Triamcinolone—multiple sclerosis	0.00247	0.00917	CrCrCtD
Fludrocortisone—Desonide—Dexamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Diflorasone—Betamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Prednisone—Dexamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Diflorasone—Dexamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Prednisone—Betamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Desonide—Betamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00246	0.00914	CrCrCtD
Fludrocortisone—Desonide—Triamcinolone—multiple sclerosis	0.00241	0.00893	CrCrCtD
Fludrocortisone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00241	0.00893	CrCrCtD
Fludrocortisone—Prednisone—Triamcinolone—multiple sclerosis	0.00241	0.00893	CrCrCtD
Fludrocortisone—Diflorasone—Triamcinolone—multiple sclerosis	0.00241	0.00893	CrCrCtD
Fludrocortisone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00238	0.00883	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00235	0.00872	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—multiple sclerosis	0.00235	0.0087	CrCrCtD
Fludrocortisone—Desoximetasone—Dexamethasone—multiple sclerosis	0.00234	0.00869	CrCrCtD
Fludrocortisone—Desoximetasone—Betamethasone—multiple sclerosis	0.00234	0.00869	CrCrCtD
Fludrocortisone—Mometasone—Methylprednisolone—multiple sclerosis	0.00233	0.00862	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00233	0.00862	CrCrCtD
Fludrocortisone—Loteprednol—Methylprednisolone—multiple sclerosis	0.00233	0.00862	CrCrCtD
Fludrocortisone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00233	0.00862	CrCrCtD
Fludrocortisone—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00233	0.00862	CrCrCtD
Fludrocortisone—Desoximetasone—Triamcinolone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Amcinonide—Prednisolone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Mometasone—Dexamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Mometasone—Betamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Triamcinolone—Dexamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Triamcinolone—Betamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Fluorometholone—Dexamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Fluorometholone—Betamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Loteprednol—Dexamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Loteprednol—Betamethasone—multiple sclerosis	0.00229	0.00849	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—multiple sclerosis	0.00229	0.00847	CrCrCtD
Fludrocortisone—Desonide—Prednisone—multiple sclerosis	0.00229	0.00847	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—multiple sclerosis	0.00229	0.00847	CrCrCtD
Fludrocortisone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00227	0.00843	CrCrCtD
Fludrocortisone—Betamethasone—Methylprednisolone—multiple sclerosis	0.00227	0.00843	CrCrCtD
Fludrocortisone—Dexamethasone—Betamethasone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Betamethasone—Dexamethasone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Loteprednol—Triamcinolone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Fluorometholone—Triamcinolone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Mometasone—Triamcinolone—multiple sclerosis	0.00224	0.00829	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00223	0.00827	CrCrCtD
Fludrocortisone—Desonide—Prednisolone—multiple sclerosis	0.00223	0.00827	CrCrCtD
Fludrocortisone—Prednisone—Prednisolone—multiple sclerosis	0.00223	0.00827	CrCrCtD
Fludrocortisone—Progesterone—Prednisolone—multiple sclerosis	0.00223	0.00827	CrCrCtD
Fludrocortisone—Diflorasone—Prednisolone—multiple sclerosis	0.00223	0.00827	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—multiple sclerosis	0.00223	0.00826	CrCrCtD
Fludrocortisone—Betamethasone—Triamcinolone—multiple sclerosis	0.00219	0.0081	CrCrCtD
Fludrocortisone—Dexamethasone—Triamcinolone—multiple sclerosis	0.00219	0.0081	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisolone—multiple sclerosis	0.00217	0.00806	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—multiple sclerosis	0.00217	0.00806	CrCrCtD
Fludrocortisone—Methylprednisolone—Betamethasone—multiple sclerosis	0.00214	0.00793	CrCrCtD
Fludrocortisone—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00214	0.00793	CrCrCtD
Fludrocortisone—Prednisolone—Methylprednisolone—multiple sclerosis	0.00213	0.00789	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisolone—multiple sclerosis	0.00212	0.00787	CrCrCtD
Fludrocortisone—Prednisolone—Dexamethasone—multiple sclerosis	0.00209	0.00776	CrCrCtD
Fludrocortisone—Prednisolone—Betamethasone—multiple sclerosis	0.00209	0.00776	CrCrCtD
Fludrocortisone—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00209	0.00775	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—multiple sclerosis	0.00207	0.00769	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—multiple sclerosis	0.00207	0.00769	CrCrCtD
Fludrocortisone—Mometasone—Prednisolone—multiple sclerosis	0.00207	0.00768	CrCrCtD
Fludrocortisone—Loteprednol—Prednisolone—multiple sclerosis	0.00207	0.00768	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.00207	0.00768	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisolone—multiple sclerosis	0.00207	0.00768	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisolone—multiple sclerosis	0.00207	0.00768	CrCrCtD
Fludrocortisone—Prednisolone—Triamcinolone—multiple sclerosis	0.00205	0.00759	CrCrCtD
Fludrocortisone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00204	0.00757	CrCrCtD
Fludrocortisone—Betamethasone—Prednisolone—multiple sclerosis	0.00202	0.00751	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisolone—multiple sclerosis	0.00202	0.00751	CrCrCtD
Fludrocortisone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00201	0.00745	CrCrCtD
Fludrocortisone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00201	0.00745	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—multiple sclerosis	0.00198	0.00735	CrCrCtD
Fludrocortisone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00196	0.00728	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—multiple sclerosis	0.00194	0.0072	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisolone—multiple sclerosis	0.00194	0.00718	CrCrCtD
Fludrocortisone—Testosterone—Prednisolone—multiple sclerosis	0.00194	0.00718	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—multiple sclerosis	0.00186	0.00691	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisolone—multiple sclerosis	0.00182	0.00674	CrCrCtD
Fludrocortisone—Dydrogesterone—PGR—multiple sclerosis	0.000315	0.282	CrCbGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000227	0.0414	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000218	0.0398	CbGpPWpGaD
Fludrocortisone—NR3C1—nerve—multiple sclerosis	0.000208	0.111	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.000201	0.0368	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—PGR—multiple sclerosis	0.00019	0.17	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000181	0.033	CbGpPWpGaD
Fludrocortisone—NR3C2—brainstem—multiple sclerosis	0.000167	0.0891	CbGeAlD
Fludrocortisone—NR3C2—retina—multiple sclerosis	0.000161	0.0859	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.000159	0.0291	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000152	0.0278	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.000145	0.0266	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000137	0.0251	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.00013	0.0238	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.00013	0.0238	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—PGR—multiple sclerosis	0.000128	0.0234	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000125	0.0228	CbGpPWpGaD
Fludrocortisone—Spironolactone—PGR—multiple sclerosis	0.000118	0.106	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.000118	0.0215	CbGpPWpGaD
Fludrocortisone—NR3C2—medulla oblongata—multiple sclerosis	0.000116	0.0621	CbGeAlD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.000112	0.0205	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.00011	0.0989	CrCbGaD
Fludrocortisone—NR3C2—midbrain—multiple sclerosis	0.000106	0.0568	CbGeAlD
Fludrocortisone—NR3C2—spinal cord—multiple sclerosis	0.000104	0.0554	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000101	0.0185	CbGpPWpGaD
Fludrocortisone—Betamethasone—PGR—multiple sclerosis	0.0001	0.0898	CrCbGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	9.71e-05	0.0177	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—VDR—multiple sclerosis	8.94e-05	0.0163	CbGpPWpGaD
Fludrocortisone—NR3C1—brainstem—multiple sclerosis	8.94e-05	0.0478	CbGeAlD
Fludrocortisone—NR3C2—nervous system—multiple sclerosis	8.73e-05	0.0467	CbGeAlD
Fludrocortisone—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	8.58e-05	0.0157	CbGpPWpGaD
Fludrocortisone—NR3C2—central nervous system—multiple sclerosis	8.41e-05	0.0449	CbGeAlD
Fludrocortisone—Triamcinolone—BCHE—multiple sclerosis	8.38e-05	0.0751	CrCbGaD
Fludrocortisone—NR3C2—cerebellum—multiple sclerosis	8.22e-05	0.0439	CbGeAlD
Fludrocortisone—Fluid retention—Prednisolone—multiple sclerosis	7.89e-05	0.00097	CcSEcCtD
Fludrocortisone—Haemoglobin—Cladribine—multiple sclerosis	7.78e-05	0.000957	CcSEcCtD
Fludrocortisone—Haemorrhage—Cladribine—multiple sclerosis	7.74e-05	0.000952	CcSEcCtD
Fludrocortisone—Pancreatitis—Azathioprine—multiple sclerosis	7.71e-05	0.000948	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	7.71e-05	0.0141	CbGpPWpGaD
Fludrocortisone—AR—spinal cord—multiple sclerosis	7.68e-05	0.041	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	7.67e-05	0.014	CbGpPWpGaD
Fludrocortisone—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	7.6e-05	0.000934	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisolone—multiple sclerosis	7.52e-05	0.000924	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	7.51e-05	0.0137	CbGpPWpGaD
Fludrocortisone—Glycosuria—Prednisone—multiple sclerosis	7.46e-05	0.000917	CcSEcCtD
Fludrocortisone—Petechiae—Prednisone—multiple sclerosis	7.34e-05	0.000903	CcSEcCtD
Fludrocortisone—Cataract—Dexamethasone—multiple sclerosis	7.29e-05	0.000896	CcSEcCtD
Fludrocortisone—Cataract—Betamethasone—multiple sclerosis	7.29e-05	0.000896	CcSEcCtD
Fludrocortisone—Fluid retention—Triamcinolone—multiple sclerosis	7.26e-05	0.000892	CcSEcCtD
Fludrocortisone—Fluid retention—Methylprednisolone—multiple sclerosis	7.24e-05	0.00089	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	7.07e-05	0.0129	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Prednisolone—multiple sclerosis	6.97e-05	0.000857	CcSEcCtD
Fludrocortisone—Oesophagitis—Methylprednisolone—multiple sclerosis	6.97e-05	0.000857	CcSEcCtD
Fludrocortisone—Asthenia—Fingolimod—multiple sclerosis	6.96e-05	0.000856	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisolone—multiple sclerosis	6.94e-05	0.000853	CcSEcCtD
Fludrocortisone—Contusion—Prednisone—multiple sclerosis	6.93e-05	0.000851	CcSEcCtD
Fludrocortisone—Ecchymosis—Triamcinolone—multiple sclerosis	6.91e-05	0.00085	CcSEcCtD
Fludrocortisone—Ecchymosis—Methylprednisolone—multiple sclerosis	6.9e-05	0.000848	CcSEcCtD
Fludrocortisone—Amenorrhoea—Prednisone—multiple sclerosis	6.88e-05	0.000845	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	6.78e-05	0.0124	CbGpPWpGaD
Fludrocortisone—Erythema—Cladribine—multiple sclerosis	6.74e-05	0.000829	CcSEcCtD
Fludrocortisone—NR3C2—brain—multiple sclerosis	6.68e-05	0.0357	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Prednisolone—multiple sclerosis	6.66e-05	0.000818	CcSEcCtD
Fludrocortisone—Fluid retention—Betamethasone—multiple sclerosis	6.59e-05	0.00081	CcSEcCtD
Fludrocortisone—Fluid retention—Dexamethasone—multiple sclerosis	6.59e-05	0.00081	CcSEcCtD
Fludrocortisone—Injury—Prednisolone—multiple sclerosis	6.57e-05	0.000807	CcSEcCtD
Fludrocortisone—AR—nervous system—multiple sclerosis	6.47e-05	0.0346	CbGeAlD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	6.44e-05	0.0118	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Triamcinolone—multiple sclerosis	6.41e-05	0.000788	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methylprednisolone—multiple sclerosis	6.4e-05	0.000786	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Triamcinolone—multiple sclerosis	6.38e-05	0.000784	CcSEcCtD
Fludrocortisone—Progesterone—PGR—multiple sclerosis	6.38e-05	0.0571	CrCbGaD
Fludrocortisone—Diabetes mellitus—Methylprednisolone—multiple sclerosis	6.37e-05	0.000783	CcSEcCtD
Fludrocortisone—Cataract—Prednisone—multiple sclerosis	6.35e-05	0.00078	CcSEcCtD
Fludrocortisone—Oesophagitis—Dexamethasone—multiple sclerosis	6.34e-05	0.000779	CcSEcCtD
Fludrocortisone—Oesophagitis—Betamethasone—multiple sclerosis	6.34e-05	0.000779	CcSEcCtD
Fludrocortisone—Haemoglobin—Azathioprine—multiple sclerosis	6.33e-05	0.000778	CcSEcCtD
Fludrocortisone—Haemorrhage—Azathioprine—multiple sclerosis	6.3e-05	0.000774	CcSEcCtD
Fludrocortisone—Ecchymosis—Betamethasone—multiple sclerosis	6.27e-05	0.000771	CcSEcCtD
Fludrocortisone—Ecchymosis—Dexamethasone—multiple sclerosis	6.27e-05	0.000771	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Prednisolone—multiple sclerosis	6.24e-05	0.000767	CcSEcCtD
Fludrocortisone—NR3C1—medulla oblongata—multiple sclerosis	6.23e-05	0.0333	CbGeAlD
Fludrocortisone—AR—central nervous system—multiple sclerosis	6.23e-05	0.0333	CbGeAlD
Fludrocortisone—Vascular purpura—Triamcinolone—multiple sclerosis	6.2e-05	0.000763	CcSEcCtD
Fludrocortisone—Sweating increased—Mitoxantrone—multiple sclerosis	6.19e-05	0.000761	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	6.15e-05	0.0112	CbGpPWpGaD
Fludrocortisone—Petechiae—Methotrexate—multiple sclerosis	6.14e-05	0.000754	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Triamcinolone—multiple sclerosis	6.12e-05	0.000752	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	6.11e-05	0.000751	CcSEcCtD
Fludrocortisone—Headache—Fingolimod—multiple sclerosis	6.08e-05	0.000747	CcSEcCtD
Fludrocortisone—Injury—Triamcinolone—multiple sclerosis	6.04e-05	0.000742	CcSEcCtD
Fludrocortisone—Injury—Methylprednisolone—multiple sclerosis	6.03e-05	0.000741	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—ZNF746—multiple sclerosis	6.01e-05	0.011	CbGpPWpGaD
Fludrocortisone—Affect lability—Prednisolone—multiple sclerosis	5.94e-05	0.00073	CcSEcCtD
Fludrocortisone—Dexamethasone—PGR—multiple sclerosis	5.83e-05	0.0522	CrCbGaD
Fludrocortisone—Thrombophlebitis—Dexamethasone—multiple sclerosis	5.82e-05	0.000715	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Betamethasone—multiple sclerosis	5.82e-05	0.000715	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Dexamethasone—multiple sclerosis	5.79e-05	0.000712	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Betamethasone—multiple sclerosis	5.79e-05	0.000712	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	5.79e-05	0.0106	CbGpPWpGaD
Fludrocortisone—Purpura—Triamcinolone—multiple sclerosis	5.76e-05	0.000708	CcSEcCtD
Fludrocortisone—Myalgia—Cladribine—multiple sclerosis	5.74e-05	0.000705	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisone—multiple sclerosis	5.74e-05	0.000705	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Mitoxantrone—multiple sclerosis	5.74e-05	0.000705	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	5.73e-05	0.000705	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	5.72e-05	0.000703	CcSEcCtD
Fludrocortisone—Mood swings—Prednisolone—multiple sclerosis	5.72e-05	0.000703	CcSEcCtD
Fludrocortisone—NR3C1—midbrain—multiple sclerosis	5.7e-05	0.0304	CbGeAlD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	5.7e-05	0.0104	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.69e-05	0.0104	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	5.69e-05	0.0104	CbGpPWpGaD
Fludrocortisone—NR3C1—spinal cord—multiple sclerosis	5.56e-05	0.0297	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Dexamethasone—multiple sclerosis	5.55e-05	0.000683	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Betamethasone—multiple sclerosis	5.55e-05	0.000683	CcSEcCtD
Fludrocortisone—Oesophagitis—Prednisone—multiple sclerosis	5.52e-05	0.000679	CcSEcCtD
Fludrocortisone—Oedema—Cladribine—multiple sclerosis	5.5e-05	0.000676	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PTBP1—multiple sclerosis	5.49e-05	0.01	CbGpPWpGaD
Fludrocortisone—Injury—Betamethasone—multiple sclerosis	5.48e-05	0.000674	CcSEcCtD
Fludrocortisone—Injury—Dexamethasone—multiple sclerosis	5.48e-05	0.000674	CcSEcCtD
Fludrocortisone—Infection—Cladribine—multiple sclerosis	5.47e-05	0.000672	CcSEcCtD
Fludrocortisone—Affect lability—Triamcinolone—multiple sclerosis	5.46e-05	0.000672	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisone—multiple sclerosis	5.46e-05	0.000672	CcSEcCtD
Fludrocortisone—Affect lability—Methylprednisolone—multiple sclerosis	5.45e-05	0.00067	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	5.36e-05	0.00979	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Prednisolone—multiple sclerosis	5.32e-05	0.000654	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cladribine—multiple sclerosis	5.32e-05	0.000654	CcSEcCtD
Fludrocortisone—Mood swings—Triamcinolone—multiple sclerosis	5.26e-05	0.000646	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisolone—multiple sclerosis	5.25e-05	0.000646	CcSEcCtD
Fludrocortisone—Mood swings—Methylprednisolone—multiple sclerosis	5.25e-05	0.000645	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Betamethasone—multiple sclerosis	5.2e-05	0.00064	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	5.2e-05	0.00064	CcSEcCtD
Fludrocortisone—Haemoglobin—Mitoxantrone—multiple sclerosis	5.12e-05	0.000629	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisolone—multiple sclerosis	5.11e-05	0.000629	CcSEcCtD
Fludrocortisone—Haemorrhage—Mitoxantrone—multiple sclerosis	5.09e-05	0.000626	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisolone—multiple sclerosis	5.08e-05	0.000625	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Prednisone—multiple sclerosis	5.07e-05	0.000623	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisone—multiple sclerosis	5.04e-05	0.00062	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cladribine—multiple sclerosis	5.01e-05	0.000616	CcSEcCtD
Fludrocortisone—Insomnia—Cladribine—multiple sclerosis	4.98e-05	0.000612	CcSEcCtD
Fludrocortisone—Affect lability—Betamethasone—multiple sclerosis	4.96e-05	0.000609	CcSEcCtD
Fludrocortisone—Affect lability—Dexamethasone—multiple sclerosis	4.96e-05	0.000609	CcSEcCtD
Fludrocortisone—AR—brain—multiple sclerosis	4.94e-05	0.0264	CbGeAlD
Fludrocortisone—Vascular purpura—Prednisone—multiple sclerosis	4.9e-05	0.000603	CcSEcCtD
Fludrocortisone—Muscular weakness—Triamcinolone—multiple sclerosis	4.9e-05	0.000602	CcSEcCtD
Fludrocortisone—Muscular weakness—Methylprednisolone—multiple sclerosis	4.88e-05	0.0006	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	4.88e-05	0.00892	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Prednisone—multiple sclerosis	4.84e-05	0.000595	CcSEcCtD
Fludrocortisone—Abdominal distension—Triamcinolone—multiple sclerosis	4.83e-05	0.000594	CcSEcCtD
Fludrocortisone—Abdominal distension—Methylprednisolone—multiple sclerosis	4.82e-05	0.000592	CcSEcCtD
Fludrocortisone—Injury—Prednisone—multiple sclerosis	4.77e-05	0.000587	CcSEcCtD
Fludrocortisone—Mood swings—Betamethasone—multiple sclerosis	4.77e-05	0.000586	CcSEcCtD
Fludrocortisone—Mood swings—Dexamethasone—multiple sclerosis	4.77e-05	0.000586	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	4.75e-05	0.00867	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Triamcinolone—multiple sclerosis	4.7e-05	0.000578	CcSEcCtD
Fludrocortisone—Pancreatitis—Methylprednisolone—multiple sclerosis	4.69e-05	0.000577	CcSEcCtD
Fludrocortisone—NR3C1—nervous system—multiple sclerosis	4.68e-05	0.025	CbGeAlD
Fludrocortisone—Sweating increased—Triamcinolone—multiple sclerosis	4.67e-05	0.000574	CcSEcCtD
Fludrocortisone—Myalgia—Azathioprine—multiple sclerosis	4.67e-05	0.000574	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	4.66e-05	0.00852	CbGpPWpGaD
Fludrocortisone—Sweating increased—Methylprednisolone—multiple sclerosis	4.66e-05	0.000573	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	4.59e-05	0.00839	CbGpPWpGaD
Fludrocortisone—Ecchymosis—Methotrexate—multiple sclerosis	4.57e-05	0.000561	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—multiple sclerosis	4.57e-05	0.000561	CcSEcCtD
Fludrocortisone—Purpura—Prednisone—multiple sclerosis	4.55e-05	0.000559	CcSEcCtD
Fludrocortisone—NR3C1—central nervous system—multiple sclerosis	4.51e-05	0.0241	CbGeAlD
Fludrocortisone—Infection—Azathioprine—multiple sclerosis	4.44e-05	0.000546	CcSEcCtD
Fludrocortisone—Muscular weakness—Dexamethasone—multiple sclerosis	4.44e-05	0.000546	CcSEcCtD
Fludrocortisone—Muscular weakness—Betamethasone—multiple sclerosis	4.44e-05	0.000546	CcSEcCtD
Fludrocortisone—Erythema—Mitoxantrone—multiple sclerosis	4.43e-05	0.000545	CcSEcCtD
Fludrocortisone—NR3C1—cerebellum—multiple sclerosis	4.41e-05	0.0236	CbGeAlD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	4.39e-05	0.00802	CbGpPWpGaD
Fludrocortisone—Urticaria—Cladribine—multiple sclerosis	4.37e-05	0.000537	CcSEcCtD
Fludrocortisone—Affect lability—Prednisone—multiple sclerosis	4.32e-05	0.000531	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	4.32e-05	0.00789	CbGpPWpGaD
Fludrocortisone—Sweating increased—Betamethasone—multiple sclerosis	4.24e-05	0.000521	CcSEcCtD
Fludrocortisone—Sweating increased—Dexamethasone—multiple sclerosis	4.24e-05	0.000521	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—multiple sclerosis	4.23e-05	0.000521	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—multiple sclerosis	4.21e-05	0.000518	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisolone—multiple sclerosis	4.2e-05	0.000516	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisolone—multiple sclerosis	4.18e-05	0.000513	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	4.17e-05	0.00761	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—U2AF2—multiple sclerosis	4.16e-05	0.00761	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HNRNPA1—multiple sclerosis	4.16e-05	0.00761	CbGpPWpGaD
Fludrocortisone—Mood swings—Prednisone—multiple sclerosis	4.15e-05	0.000511	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	4.09e-05	0.00748	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	4.08e-05	0.000501	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cladribine—multiple sclerosis	4.05e-05	0.000498	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	4.05e-05	0.0074	CbGpPWpGaD
Fludrocortisone—Asthenia—Cladribine—multiple sclerosis	3.95e-05	0.000485	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	3.94e-05	0.00719	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Dexamethasone—multiple sclerosis	3.93e-05	0.000483	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Betamethasone—multiple sclerosis	3.93e-05	0.000483	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	3.89e-05	0.00711	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Prednisone—multiple sclerosis	3.87e-05	0.000476	CcSEcCtD
Fludrocortisone—Haemoglobin—Triamcinolone—multiple sclerosis	3.86e-05	0.000474	CcSEcCtD
Fludrocortisone—Haemoglobin—Methylprednisolone—multiple sclerosis	3.85e-05	0.000473	CcSEcCtD
Fludrocortisone—Haemorrhage—Triamcinolone—multiple sclerosis	3.84e-05	0.000472	CcSEcCtD
Fludrocortisone—Convulsion—Mitoxantrone—multiple sclerosis	3.84e-05	0.000472	CcSEcCtD
Fludrocortisone—Haemorrhage—Methylprednisolone—multiple sclerosis	3.83e-05	0.000471	CcSEcCtD
Fludrocortisone—Hypertension—Mitoxantrone—multiple sclerosis	3.83e-05	0.00047	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisone—multiple sclerosis	3.82e-05	0.000469	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	3.79e-05	0.000466	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	3.78e-05	0.00691	CbGpPWpGaD
Fludrocortisone—Myalgia—Mitoxantrone—multiple sclerosis	3.77e-05	0.000464	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PGR—multiple sclerosis	3.76e-05	0.00688	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Prednisone—multiple sclerosis	3.72e-05	0.000457	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	3.7e-05	0.00676	CbGpPWpGaD
Fludrocortisone—Sweating increased—Prednisone—multiple sclerosis	3.69e-05	0.000454	CcSEcCtD
Fludrocortisone—Erythema—Prednisolone—multiple sclerosis	3.63e-05	0.000447	CcSEcCtD
Fludrocortisone—Oedema—Mitoxantrone—multiple sclerosis	3.62e-05	0.000444	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	3.62e-05	0.000444	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	3.6e-05	0.00658	CbGpPWpGaD
Fludrocortisone—Infection—Mitoxantrone—multiple sclerosis	3.59e-05	0.000442	CcSEcCtD
Fludrocortisone—NR3C1—brain—multiple sclerosis	3.58e-05	0.0191	CbGeAlD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	3.57e-05	0.00652	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Betamethasone—multiple sclerosis	3.5e-05	0.00043	CcSEcCtD
Fludrocortisone—Haemoglobin—Dexamethasone—multiple sclerosis	3.5e-05	0.00043	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	3.5e-05	0.00043	CcSEcCtD
Fludrocortisone—Haemorrhage—Betamethasone—multiple sclerosis	3.48e-05	0.000428	CcSEcCtD
Fludrocortisone—Haemorrhage—Dexamethasone—multiple sclerosis	3.48e-05	0.000428	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—multiple sclerosis	3.47e-05	0.000427	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	3.47e-05	0.00634	CbGpPWpGaD
Fludrocortisone—Headache—Cladribine—multiple sclerosis	3.45e-05	0.000424	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—multiple sclerosis	3.42e-05	0.00042	CcSEcCtD
Fludrocortisone—Erythema—Triamcinolone—multiple sclerosis	3.34e-05	0.000411	CcSEcCtD
Fludrocortisone—Erythema—Methylprednisolone—multiple sclerosis	3.34e-05	0.00041	CcSEcCtD
Fludrocortisone—Hypersensitivity—Azathioprine—multiple sclerosis	3.3e-05	0.000405	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	3.29e-05	0.000405	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	3.29e-05	0.00601	CbGpPWpGaD
Fludrocortisone—Vertigo—Prednisolone—multiple sclerosis	3.27e-05	0.000401	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	3.23e-05	0.0059	CbGpPWpGaD
Fludrocortisone—Convulsion—Prednisolone—multiple sclerosis	3.15e-05	0.000387	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	3.14e-05	0.00573	CbGpPWpGaD
Fludrocortisone—Hypertension—Prednisolone—multiple sclerosis	3.14e-05	0.000386	CcSEcCtD
Fludrocortisone—Prednisone—ALB—multiple sclerosis	3.12e-05	0.028	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.12e-05	0.0057	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Methotrexate—multiple sclerosis	3.11e-05	0.000382	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisone—multiple sclerosis	3.05e-05	0.000375	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisone—multiple sclerosis	3.03e-05	0.000373	CcSEcCtD
Fludrocortisone—Erythema—Betamethasone—multiple sclerosis	3.03e-05	0.000373	CcSEcCtD
Fludrocortisone—Erythema—Dexamethasone—multiple sclerosis	3.03e-05	0.000373	CcSEcCtD
Fludrocortisone—Vertigo—Triamcinolone—multiple sclerosis	3e-05	0.000369	CcSEcCtD
Fludrocortisone—Vertigo—Methylprednisolone—multiple sclerosis	3e-05	0.000368	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisolone—multiple sclerosis	2.97e-05	0.000365	CcSEcCtD
Fludrocortisone—Oedema—Prednisolone—multiple sclerosis	2.97e-05	0.000365	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	2.94e-05	0.00538	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—multiple sclerosis	2.92e-05	0.0262	CrCbGaD
Fludrocortisone—Convulsion—Triamcinolone—multiple sclerosis	2.9e-05	0.000356	CcSEcCtD
Fludrocortisone—Convulsion—Methylprednisolone—multiple sclerosis	2.89e-05	0.000355	CcSEcCtD
Fludrocortisone—Hypertension—Triamcinolone—multiple sclerosis	2.89e-05	0.000355	CcSEcCtD
Fludrocortisone—Hypertension—Methylprednisolone—multiple sclerosis	2.88e-05	0.000354	CcSEcCtD
Fludrocortisone—Urticaria—Mitoxantrone—multiple sclerosis	2.87e-05	0.000353	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Prednisolone—multiple sclerosis	2.87e-05	0.000353	CcSEcCtD
Fludrocortisone—Myalgia—Triamcinolone—multiple sclerosis	2.85e-05	0.00035	CcSEcCtD
Fludrocortisone—Myalgia—Methylprednisolone—multiple sclerosis	2.84e-05	0.000349	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	2.81e-05	0.00513	CbGpPWpGaD
Fludrocortisone—Headache—Azathioprine—multiple sclerosis	2.8e-05	0.000344	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	2.8e-05	0.00511	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ZNF746—multiple sclerosis	2.79e-05	0.00509	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	2.76e-05	0.00504	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Triamcinolone—multiple sclerosis	2.73e-05	0.000335	CcSEcCtD
Fludrocortisone—Oedema—Triamcinolone—multiple sclerosis	2.73e-05	0.000335	CcSEcCtD
Fludrocortisone—Vertigo—Dexamethasone—multiple sclerosis	2.72e-05	0.000335	CcSEcCtD
Fludrocortisone—Vertigo—Betamethasone—multiple sclerosis	2.72e-05	0.000335	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	2.72e-05	0.000335	CcSEcCtD
Fludrocortisone—Infection—Triamcinolone—multiple sclerosis	2.71e-05	0.000333	CcSEcCtD
Fludrocortisone—Infection—Methylprednisolone—multiple sclerosis	2.7e-05	0.000332	CcSEcCtD
Fludrocortisone—Insomnia—Prednisolone—multiple sclerosis	2.68e-05	0.00033	CcSEcCtD
Fludrocortisone—Hypersensitivity—Mitoxantrone—multiple sclerosis	2.66e-05	0.000327	CcSEcCtD
Fludrocortisone—Erythema—Prednisone—multiple sclerosis	2.64e-05	0.000325	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Triamcinolone—multiple sclerosis	2.64e-05	0.000324	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	2.63e-05	0.000323	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	2.63e-05	0.00481	CbGpPWpGaD
Fludrocortisone—Convulsion—Dexamethasone—multiple sclerosis	2.63e-05	0.000323	CcSEcCtD
Fludrocortisone—Convulsion—Betamethasone—multiple sclerosis	2.63e-05	0.000323	CcSEcCtD
Fludrocortisone—Hypertension—Dexamethasone—multiple sclerosis	2.62e-05	0.000322	CcSEcCtD
Fludrocortisone—Hypertension—Betamethasone—multiple sclerosis	2.62e-05	0.000322	CcSEcCtD
Fludrocortisone—Asthenia—Mitoxantrone—multiple sclerosis	2.59e-05	0.000319	CcSEcCtD
Fludrocortisone—Myalgia—Dexamethasone—multiple sclerosis	2.58e-05	0.000317	CcSEcCtD
Fludrocortisone—Myalgia—Betamethasone—multiple sclerosis	2.58e-05	0.000317	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PABPC1—multiple sclerosis	2.55e-05	0.00466	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PTBP1—multiple sclerosis	2.55e-05	0.00466	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Methotrexate—multiple sclerosis	2.55e-05	0.000313	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—multiple sclerosis	2.54e-05	0.000312	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	2.52e-05	0.00461	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.5e-05	0.00457	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.49e-05	0.000306	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.48e-05	0.000305	CcSEcCtD
Fludrocortisone—Oedema—Dexamethasone—multiple sclerosis	2.48e-05	0.000304	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Betamethasone—multiple sclerosis	2.48e-05	0.000304	CcSEcCtD
Fludrocortisone—Oedema—Betamethasone—multiple sclerosis	2.48e-05	0.000304	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.48e-05	0.000304	CcSEcCtD
Fludrocortisone—Insomnia—Triamcinolone—multiple sclerosis	2.47e-05	0.000303	CcSEcCtD
Fludrocortisone—Insomnia—Methylprednisolone—multiple sclerosis	2.46e-05	0.000303	CcSEcCtD
Fludrocortisone—Infection—Betamethasone—multiple sclerosis	2.46e-05	0.000302	CcSEcCtD
Fludrocortisone—Infection—Dexamethasone—multiple sclerosis	2.46e-05	0.000302	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Betamethasone—multiple sclerosis	2.39e-05	0.000294	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Dexamethasone—multiple sclerosis	2.39e-05	0.000294	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	2.38e-05	0.00435	CbGpPWpGaD
Fludrocortisone—Vertigo—Prednisone—multiple sclerosis	2.37e-05	0.000292	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	2.37e-05	0.00433	CbGpPWpGaD
Fludrocortisone—Urticaria—Prednisolone—multiple sclerosis	2.36e-05	0.00029	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—RPL5—multiple sclerosis	2.3e-05	0.00421	CbGpPWpGaD
Fludrocortisone—Convulsion—Prednisone—multiple sclerosis	2.29e-05	0.000281	CcSEcCtD
Fludrocortisone—Hypertension—Prednisone—multiple sclerosis	2.28e-05	0.00028	CcSEcCtD
Fludrocortisone—Headache—Mitoxantrone—multiple sclerosis	2.27e-05	0.000278	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.26e-05	0.000277	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.26e-05	0.000277	CcSEcCtD
Fludrocortisone—Myalgia—Prednisone—multiple sclerosis	2.25e-05	0.000276	CcSEcCtD
Fludrocortisone—Insomnia—Dexamethasone—multiple sclerosis	2.24e-05	0.000275	CcSEcCtD
Fludrocortisone—Insomnia—Betamethasone—multiple sclerosis	2.24e-05	0.000275	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	2.23e-05	0.00408	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FAS—multiple sclerosis	2.21e-05	0.00404	CbGpPWpGaD
Fludrocortisone—Erythema—Methotrexate—multiple sclerosis	2.21e-05	0.000271	CcSEcCtD
Fludrocortisone—Hypersensitivity—Prednisolone—multiple sclerosis	2.19e-05	0.000269	CcSEcCtD
Fludrocortisone—Urticaria—Triamcinolone—multiple sclerosis	2.17e-05	0.000266	CcSEcCtD
Fludrocortisone—Urticaria—Methylprednisolone—multiple sclerosis	2.16e-05	0.000266	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—multiple sclerosis	2.16e-05	0.000265	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisone—multiple sclerosis	2.16e-05	0.000265	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.14e-05	0.00391	CbGpPWpGaD
Fludrocortisone—Infection—Prednisone—multiple sclerosis	2.14e-05	0.000263	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	2.13e-05	0.0039	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	2.12e-05	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	2.11e-05	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	2.1e-05	0.00383	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Prednisone—multiple sclerosis	2.08e-05	0.000256	CcSEcCtD
Fludrocortisone—Hypersensitivity—Triamcinolone—multiple sclerosis	2.01e-05	0.000247	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.01e-05	0.000247	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	2e-05	0.00366	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—multiple sclerosis	1.98e-05	0.000244	CcSEcCtD
Fludrocortisone—Urticaria—Dexamethasone—multiple sclerosis	1.97e-05	0.000242	CcSEcCtD
Fludrocortisone—Urticaria—Betamethasone—multiple sclerosis	1.97e-05	0.000242	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	1.96e-05	0.000241	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	1.96e-05	0.00358	CbGpPWpGaD
Fludrocortisone—Asthenia—Triamcinolone—multiple sclerosis	1.96e-05	0.000241	CcSEcCtD
Fludrocortisone—Asthenia—Methylprednisolone—multiple sclerosis	1.95e-05	0.00024	CcSEcCtD
Fludrocortisone—Insomnia—Prednisone—multiple sclerosis	1.95e-05	0.00024	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.94e-05	0.00354	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	1.94e-05	0.00354	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.93e-05	0.00353	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—U2AF2—multiple sclerosis	1.93e-05	0.00353	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HNRNPA1—multiple sclerosis	1.93e-05	0.00353	CbGpPWpGaD
Fludrocortisone—Convulsion—Methotrexate—multiple sclerosis	1.91e-05	0.000235	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—multiple sclerosis	1.88e-05	0.000231	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.86e-05	0.0034	CbGpPWpGaD
Fludrocortisone—Headache—Prednisolone—multiple sclerosis	1.86e-05	0.000228	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PGR—multiple sclerosis	1.81e-05	0.00331	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—multiple sclerosis	1.8e-05	0.000221	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—multiple sclerosis	1.79e-05	0.00022	CcSEcCtD
Fludrocortisone—Asthenia—Betamethasone—multiple sclerosis	1.78e-05	0.000218	CcSEcCtD
Fludrocortisone—Asthenia—Dexamethasone—multiple sclerosis	1.78e-05	0.000218	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	1.75e-05	0.00319	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Methotrexate—multiple sclerosis	1.74e-05	0.000214	CcSEcCtD
Fludrocortisone—Urticaria—Prednisone—multiple sclerosis	1.71e-05	0.000211	CcSEcCtD
Fludrocortisone—Headache—Triamcinolone—multiple sclerosis	1.71e-05	0.00021	CcSEcCtD
Fludrocortisone—Headache—Methylprednisolone—multiple sclerosis	1.71e-05	0.00021	CcSEcCtD
Fludrocortisone—Testosterone—ALB—multiple sclerosis	1.69e-05	0.0152	CrCbGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.69e-05	0.00309	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.65e-05	0.00302	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.65e-05	0.00301	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.64e-05	0.000202	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—multiple sclerosis	1.63e-05	0.0002	CcSEcCtD
Fludrocortisone—Hypersensitivity—Prednisone—multiple sclerosis	1.59e-05	0.000195	CcSEcCtD
Fludrocortisone—Headache—Betamethasone—multiple sclerosis	1.55e-05	0.000191	CcSEcCtD
Fludrocortisone—Headache—Dexamethasone—multiple sclerosis	1.55e-05	0.000191	CcSEcCtD
Fludrocortisone—Asthenia—Prednisone—multiple sclerosis	1.55e-05	0.00019	CcSEcCtD
Fludrocortisone—AR—Gene Expression—ZFP36L1—multiple sclerosis	1.53e-05	0.00279	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.47e-05	0.00269	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.47e-05	0.00269	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.47e-05	0.00268	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.47e-05	0.00268	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—multiple sclerosis	1.43e-05	0.000176	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.43e-05	0.0026	CbGpPWpGaD
Fludrocortisone—Headache—Prednisone—multiple sclerosis	1.35e-05	0.000166	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methotrexate—multiple sclerosis	1.33e-05	0.000163	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.33e-05	0.00242	CbGpPWpGaD
Fludrocortisone—Asthenia—Methotrexate—multiple sclerosis	1.29e-05	0.000159	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—VDR—multiple sclerosis	1.27e-05	0.00231	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	1.24e-05	0.00227	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	1.22e-05	0.00223	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PABPC1—multiple sclerosis	1.18e-05	0.00216	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.18e-05	0.00215	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.16e-05	0.00212	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.15e-05	0.00211	CbGpPWpGaD
Fludrocortisone—Headache—Methotrexate—multiple sclerosis	1.13e-05	0.000139	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.12e-05	0.00204	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.1e-05	0.002	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.08e-05	0.00198	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.07e-05	0.00195	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL5—multiple sclerosis	1.07e-05	0.00195	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	1.05e-05	0.00191	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	1.01e-05	0.00184	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.77e-06	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.74e-06	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.55e-06	0.00175	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—multiple sclerosis	9.39e-06	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	9.26e-06	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.1e-06	0.00166	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	8.98e-06	0.00164	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.63e-06	0.00158	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PGR—multiple sclerosis	8.41e-06	0.00154	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.11e-06	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL5—multiple sclerosis	8.1e-06	0.00148	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—multiple sclerosis	7.58e-06	0.00138	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.55e-06	0.0012	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PGR—multiple sclerosis	6.38e-06	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—VDR—multiple sclerosis	5.88e-06	0.00107	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—multiple sclerosis	5.03e-06	0.00092	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	4.85e-06	0.000886	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—VDR—multiple sclerosis	4.46e-06	0.000815	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	3.68e-06	0.000672	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—multiple sclerosis	2.34e-06	0.000427	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—multiple sclerosis	1.77e-06	0.000324	CbGpPWpGaD
